Special Session 2: Benchmarking and Standardization in Software-Based SER Characterization: Towards an IEEE Task Force?

2008 14th IEEE International On-Line Testing Symposium Pub Date : 2008-07-07 DOI:10.1109/IOLTS.2008.67

M. Nicolaidis

引用次数: 2

Abstract

The present invention provides novel ophthalmic drug delivery formulation which comprises a mixture of Carbopol and Pluronic. Carbopol is a trademark of B.F. Goodrich Company's high molecular weight carboxy vinyl polymers (MW above 1,000,000). Pluronic belongs to a class of block copolymers containing polyoxyethylene and polyoxypropylene. The preferred weight percentages of Carbopol and Pluronic in the ophthalmic drug delivery formulation are 0.3% of Carbopol and 14% of Pluronic. The ocular bioavailability is greatly enhanced by the use of the ophthalmic drug delivery formulation of the present invention.

查看原文本刊更多论文

特别会议2:基于软件的SER特性的基准和标准化:迈向IEEE工作组?

本发明提供了一种新型眼科给药制剂，其包括卡泊泊和Pluronic的混合物。Carbopol是B.F. Goodrich公司的高分子量羧基乙烯基聚合物(MW高于1,000,000)的商标。Pluronic属于一类含有聚氧乙烯和聚氧丙烯的嵌段共聚物。卡波波尔和Pluronic在眼科给药配方中的优选重量百分比为卡波波尔的0.3%和Pluronic的14%。通过使用本发明的眼科给药制剂，眼部生物利用度大大提高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

2008 14th IEEE International On-Line Testing Symposium

自引率

0.00%

发文量